4.09
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BNGO?
Forum
Prognose
Aktiensplit
Finanzdaten der Bionano Genomics Inc-Aktie (BNGO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
4.27%
6.733
|
6.457 | 7.771 | 8.769 | 10.72 |
Cost Of Revenue |
7.47%
3.256
|
3.519 | 5.186 | 5.945 | 8.283 |
Gross Profit |
18.35%
3.477
|
2.938 | 2.585 | 2.824 | 2.438 |
|
1.10%
11.28
|
11.40 | 19.60 | 33.95 | 27.39 |
Benefits Costs and Expenses |
42.17%
13.58
|
9.552 | 23.97 | 40.21 | 54.65 |
Costs And Expenses |
1.10%
11.28
|
11.40 | 19.60 | 33.95 | 27.39 |
Operating Income/Loss |
7.86%
-7.80
|
-8.465 | -17.02 | -31.12 | -24.95 |
Nonoperating Income/Loss |
82.25%
0.953
|
5.37 | 0.82 | -0.317 | -18.97 |
Income/Loss From Continuing Operations Before Tax |
121.23%
-6.847
|
-3.095 | -16.20 | -31.44 | -43.93 |
Income Tax Expense/Benefit |
42.86%
0.01
|
0.007 | 0.026 | -0.018 | -0.036 |
Income/Loss From Continuing Operations After Tax |
121.05%
-6.857
|
-3.102 | -16.22 | -31.42 | -43.89 |
|
121.05%
-6.857
|
-3.102 | -16.22 | -31.42 | -43.89 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
27.73%
3.441
|
2.694 | 67.58 | 52.74 | 1.904 |
Diluted Average Shares |
27.73%
3.441
|
2.694 | 67.58 | 52.74 | 1.904 |
Basic Earnings Per Share |
73.04%
-1.99
|
-1.15 | -0.24 | -0.60 | -0.96 |
Diluted Earnings Per Share |
73.04%
-1.99
|
-1.15 | -0.24 | -0.60 | -0.96 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):